Abstract | PURPOSE: MATERIALS AND METHODS: RESULTS: In comparative analysis of the occurrence of poor outcomes among patients taking AZA only, MMF only, and MMF after AZA, patients taking MMF only exhibited a significantly lower cumulative ESRD-free survival rate than patients taking AZA only (p=0.028). In terms of ESRD occurrence between the groups based on BVAS at diagnosis, among patients with MPA and GPA with higher BVAS at diagnosis, patients taking MMF only exhibited a significantly lower cumulative ESRD-free survival rate than those taking AZA only (p=0.047). Among patients with MPA and GPA with the lowest tertile of BVAS at diagnosis, cumulative ESRD-free survival rates did not differ. CONCLUSION: With regard to ESRD occurrence, the efficacy of MMF in remission maintenance therapy was less effective than AZA in patients with MPA and GPA. However, among patients with lower BVAS, there was no difference in the occurrence of poor outcomes between patients taking MMF and those taking AZA.
|
Authors | Jung Yoon Pyo, Lucy Eunju Lee, Sung Soo Ahn, Jason Jungsik Song, Yong Beom Park, Sang Won Lee |
Journal | Yonsei medical journal
(Yonsei Med J)
Vol. 62
Issue 6
Pg. 494-502
(Jun 2021)
ISSN: 1976-2437 [Electronic] Korea (South) |
PMID | 34027636
(Publication Type: Journal Article)
|
Copyright | © Copyright: Yonsei University College of Medicine 2021. |
Chemical References |
- Immunosuppressive Agents
- Mycophenolic Acid
- Azathioprine
|
Topics |
- Azathioprine
(therapeutic use)
- Granulomatosis with Polyangiitis
(drug therapy)
- Humans
- Immunosuppressive Agents
(therapeutic use)
- Microscopic Polyangiitis
(drug therapy)
- Mycophenolic Acid
(therapeutic use)
- Treatment Outcome
|